Clinical Edge Journal Scan

Osteophytes are the most common lesions in PsA patients receiving bDMARD


 

Key clinical point: A substantial proportion of patients with psoriatic arthritis (PsA) who received biological disease-modifying antirheumatic drug (bDMARD) therapy showed osteoproliferative lesions on a lumbar radiograph, with osteophytes being the most common.

Major finding: Osteophytes were the most common lesions and were detected in 42.3% of patients, with 18.1% of patients being diagnosed with grade ≥2 osteophytes. At least one syndesmophyte was detected in 24.2% of patients, with 9.3% and 19.8% of patients showing bridging and corner syndesmophytes, respectively. Ambiguous lesions were detected in 7.1% of patients.

Study details: Findings are from an analysis of 182 patients with PsA who received bDMARD therapy and underwent lumbar radiography assessment.

Disclosures: This research was funded by Hacettepe Rheumatology Society, Turkey. The authors declared no conflicts of interest.

Source: Ayan G et al. Degenerative and inflammatory osteoproliferations in lumbar radiographs in psoriatic arthritis patients. J Clin Med. 2022;11(7):2009 (Apr 3). Doi: 10.3390/jcm11072009

Recommended Reading

Upadacitinib earns FDA approval for ankylosing spondylitis 
Psoriatic Arthritis ICYMI
Reduced-frequency methotrexate monitoring causes no harm
Psoriatic Arthritis ICYMI
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
Psoriatic Arthritis ICYMI
Severe infections often accompany severe psoriasis
Psoriatic Arthritis ICYMI
Man with distal flexion deformities
Psoriatic Arthritis ICYMI
FDA approves topical tapinarof for plaque psoriasis
Psoriatic Arthritis ICYMI
Improved outcomes with 6-month secukinumab use in PsA
Psoriatic Arthritis ICYMI
Sex and BMI affect response to systemic PsA therapy
Psoriatic Arthritis ICYMI
PsA: Real-world efficacy, safety, and retention rate of secukinumab
Psoriatic Arthritis ICYMI
Site of infection linked to PsA onset regardless of pathogen
Psoriatic Arthritis ICYMI